1-(3-(3-Chlorophenyl)-4-methoxybenzyl)-3-methyl-piperidine

Names and Identifiers

Canonical SMILES: COc1ccc(CN2CCCC(C)C2)cc1-c1cccc(Cl)c1

Standard InChI: InChI=1S/C20H24ClNO/c1-15-5-4-10-22(13-15)14-16-8-9-20(23-2)19(11-16)17-6-3-7-18(21)12-17/h3,6-9,11-12,15H,4-5,10,13-14H2,1-2H3

Standard InChI Key: WXTKZPYCIMNDEU-UHFFFAOYSA-N

Molfile:

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   14.3861  -17.2146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3850  -18.0342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0930  -18.4431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8027  -18.0337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7998  -17.2110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0912  -16.8058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6788  -18.4425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9711  -18.0316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2636  -18.4390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2625  -19.2570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9749  -19.6660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6795  -19.2563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5110  -18.4412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2181  -18.0315    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.6783  -16.8062    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6781  -15.9890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9771  -20.4832    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   17.9209  -18.4423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6258  -18.0361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6288  -17.2186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9206  -16.8089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2094  -17.2168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9221  -15.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  2  7  1  0
  4 13  1  0
 13 14  1  0
  1 15  1  0
 15 16  1  0
 11 17  1  0
 14 18  1  0
 14 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
M  END

Alternative Forms

Parent:

ALA4552861
---

Associated Targets(Human)

PDE4B Tclin Phosphodiesterase 4B (2748 Activities)

Discover Target: PDE4B

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Molecule Features

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Unknown	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Drug Indications

MESH ID	MESH Heading	EFO IDs	EFO Terms	Max Phase for Indication	References

Mechanisms of Action

Mechanism of Action	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	References

Calculated Properties

Molecular Weight: 329.87	Molecular Weight (Monoisotopic): 329.1546	AlogP: 5.25	#Rotatable Bonds: 4
Polar Surface Area: 12.47	Molecular Species: BASE	HBA: 2	HBD: ┄
#RO5 Violations: 1	HBA (Lipinski): 2	HBD (Lipinski): ┄	#RO5 Violations (Lipinski): 1
CX Acidic pKa: ┄	CX Basic pKa: 9.22	CX LogP: 5.22	CX LogD: 3.41
Aromatic Rings: 2	Heavy Atoms: 23	QED Weighted: 0.76	Np Likeness Score: -1.13

References

1. Tang L, Huang C, Zhong J, He J, Guo J, Liu M, Xu JP, Wang HT, Zhou ZZ.. (2019) Discovery of arylbenzylamines as PDE4 inhibitors with potential neuroprotective effect., 168 [PMID:30822711] [10.1016/j.ejmech.2019.02.026]

Source

Source(1):

Scientific Literature